Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population

Neuroscience Letters

Volumn 435, Issue 2, 2008, Pages 95-98

  Ji, Xiaofei ^a   Takahashi, Nagahide ^a   Saito, Shinichi ^a   Ishihara, Ryoko ^a   Maeno, Nobuhisa ^a   Inada, Toshiya ^b   Ozaki, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Antipsychotic drug; Gene; Haplotype; HTR; Refractory; Serotonin

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; MARKER; SEROTONIN 2A RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MUTATION; POPULATION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SCHIZOPHRENIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTATION; PHARMACOGENETICS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SCHIZOPHRENIA;

EID: 41149137997     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.01.083     Document Type: Article

References (28)

1. American Psychiatric Association, Diagnostic and statistical manual of mental disorders, third edition, revised, Chapter 3: the diagnostic categories: text and criteria. Washington, DC. 1987, pp. 194-196.
2. Andree T.H., Mikuni M., Tong C.Y., Koenig J.I., and Meltzer H.Y. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J. Neurochem. 46 1 (1986) 191-197
3. Ashby C.R., Edwards E., Harkins K.L., and Wang R.Y. Differential effect of typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medical prefrontal cortical cells: a microiontophoretic study. Eur. J. Pharmacol. 166 3 (1989) 583-584
4. Bediou B., Franck N., Saoud M., Baudouin J.Y., Tiberghien G., and Dalery J. Effects of emotion and identity on facial affect processing in schizophrenia. Psychiatry Res. 133 2/3 (2005) 149-157
5. Bloom F.E., and Morales M. The central 5-HT3 receptor in CNS disorders. Neurochem. Res. 23 5 (1998) 653-659
6. Farde L., Nordstrom A.L., Nyberg S., Halldin C., and Sedvall G. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. J. Clin. Psychiatry 55 Suppl. B (1994) 67-69
7. Grinshpoon A., Valevski A., Moskowitz M., and Weizman A. Beneficial effect of the addition of the 5-HT 2A/2C and alpha2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients. Eur. Psychiatry 15 6 (2000) 388-390
8. Gutierrez B., Arranz M.J., Huezo-Diaz P., Dempster D., Mathiasson P., and Travis M. Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr. Res. 58 1 (2002) 93-97
9. Hellewell J.S. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward. J. Clin. Psychiatry 60 Suppl. 23 (1999) 14-19
10. Iidaka T., Ozaki N., Matsumoto A., Nogawa J., Kinoshita Y., and Suzuki T. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J. Neurosci. 25 27 (2005) 6460-6466
11. Inada T., Nakamura A., and Lijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 120 1 (2003) 35-39
12. Inada T., Sugita T., Dobashi I., Inagaki A., Kitao Y., and Matsuda G. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first-break schizophrenic patients. Psychiatr. Genet. 5 (1995) 113-116
13. Joober R., Benkelfat C., Brisebois K., Toulouse A., Turecki G., and Lal S. T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J. Psychiatry Neurosci. 24 2 (1999) 141-146
14. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45 9 (1988) 789-796
15. Koyama S., Matsumoto N., Kubo C., and Akaike N. Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons. J. Physiol. 529 Pt 2 (2000) 373-383
16. Levinson D.F., Mahtani M.M., Nancarrow D.J., Brown D.M., Kruglyak L., and Kirby A. Genome scan of schizophrenia. Am. J. Psychiatry 155 6 (1998) 741-750
17. Malhotra A.K., Goldman D., Ozaki N., Breier A., Buchanan R., and Pickar D. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am. J. Psychiatry 153 8 (1996) 1092-1094
18. Martin F., Baudouin J.Y., Tiberghien G., and Franck N. Processing emotional expression and facial identity in schizophrenia. Psychiatry Res. 134 1 (2005) 43-53
19. Maziade M., Raymond V., Cliche D., Fournier J.P., Caron C., and Garneau Y. Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am. J. Med. Genet. 60 6 (1995) 522-528
20. Meltzer H.Y. Clozapine: is another view valid?. Am. J. Psychiatry 152 6 (1995) 821-825
21. Meltzer H.Y., and Nash J.F. Effects of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43 4 (1991) 587-604
22. Niesler B., Flohr T., Nothen M.M., Fischer C., Rietschel M., and Franzek E. Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 11 6 (2001) 471-475
23. Nordstrom A.L., Farde L., and Halldin C. High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET. Psychopharmacology (Berl.) 110 3 (1993) 365-367
24. Rammes G., Eisensamer B., Ferrari U., Shapa M., Gimpl G., and Gilling K. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol. Psychiatry 9 9 (2004) 846-858 818
25. Suzuki T., Iwata N., Kitamura Y., Kitajima T., Yamanouchi Y., and Ikeda M. Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 121 1 (2003) 7-13
26. van Hooft J.A., and Vijverberg H.P. 5-HT(3) receptors and neurotransmitter release in the CNS: a nerve ending story?. Trends Neurosci. 23 12 (2000) 605-610
27. Weiss E.L., Longhurst J.G., Bowers M.B., and Mazure C.M. Olanzapine for treatment-refractory psychosis in patients responsive to clozapine. J. Clin. Psychopharmacol. 19 4 (1999) 378-380
28. Wilson W.H. Time required for initial improvement during clozapine treatment of refractory schizophrenia. Am. J. Psychiatry 153 7 (1996) 951-952